Press Releases

-Once-daily oral ALK2 inhibitor approved to reduce the volume of total new heterotopic ossification in patients aged 12 years and older with FOP -Atebrioz expected to be available in the United States in October through Mirum Access Plus (MAP), with eligible patients paying as little as $0 per month -PROGRESS pediatric development program continues to evaluate zilurgisertib in children aged 2 to <12 years Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) and Incyte (NASDAQ:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 y

Masco Corporation (NYSE:MAS) announced today that its Chairman Emeritus Richard Manoogian passed away on September 25, 2026, at the age of 90. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925825143/en/ Richard Manoogian was the son of Alex and Marie Manoogian. Alex, an Armenian immigrant and founder of Masco Corporation, brought to market the single-handle Delta® faucet, which today is a leading brand in the home improvement and remodeling industry. Richard joined Masco in 1958. With his strong leadership skills, he was elected to Masco's Board in 1964 and named President and Chief Operating Officer in 1968. In his mid-tw

SOUTHLAKE, Texas, Sept. 25, 2026 /PRNewswire/ -- Sabre Corporation ("Sabre") (NASDAQ:SABR) today announced the early tender results of the previously announced cash tender offer (the "Tender Offer") by Sabre Financial Borrower, LLC ("Sabre Financial"), its indirect wholly-owned subsidiary, for any and all of Sabre Financial's securities set forth in the table below (the "Securities") and concurrent solicitation of consents (the "Consent Solicitation") to certain proposed amendments to the Securities and the Indenture (as defined below). The Tender Offer and Consent Solicitation will expire at 5:00 p.m., New York City time, on October 12, 2026 (unless extended or earlier terminated, the "Expi

IRVINE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Skyworks Solutions, Inc. (NASDAQ:SWKS) ("Skyworks"), a leading developer, manufacturer and provider of analog and mixed-signal semiconductors and solutions for numerous applications, today announced that it has extended the expiration date of its previously announced offers to holders of Qorvo Notes (as defined herein) to exchange (the "Exchange Offers") any and all outstanding 4.375% Senior Notes due 2029 (the "2029 Qorvo Notes") and any and all outstanding 3.375% Senior Notes due 2031 (the "2031 Qorvo Notes" and, together with the 2029 Qorvo Notes, the "Qorvo Notes") issued by Qorvo, Inc. ("Qorvo") as set forth in the table below for (1)

Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE:MMI) dedicated to serving the company’s institutional clients, announced today the sale of Ascend at Black Canyon, a 260-unit multifamily property in Phoenix, Arizona. The asset traded for $58.7 million, or $225,769 per unit."North Phoenix is positioned to generate tens of thousands of high-earning jobs supporting the world’s most advanced nanometer chip production for companies such as Apple, Sony, Tesla, and Qualcomm," said Steve Gebing, IPA executive managing director investments. "Within a one-mile radius of Ascend at Black Canyon, average and median annual household incomes are $163,500 and $138,000, respectiv

NEW YORK, Sept. 25, 2026 /PRNewswire/ -- Warner Bros. Discovery, Inc. (NASDAQ:WBD) ("WBD" or "Warner Bros. Discovery") today announced that, in connection with the pending acquisition of WBD (the "Acquisition") by Paramount Skydance Corporation ("PSKY"), which is subject to the satisfaction of customary closing conditions, WBD intends to voluntarily delist from The Nasdaq Global Market ("Nasdaq Global") the 4.302% Senior Notes due 2030 issued by Discovery Global Holdings, Inc., a wholly owned subsidiary of WBD ("DGH"), and fully and unconditionally guaranteed by WBD and certain of its subsidiaries and the 4.693% Senior Notes due 2033 issued by DGH and fully and unconditionally guaranteed by

Kodiak Sciences to Host Webcast on Monday, September 28 at 8:30 AM Eastern Time PALO ALTO, Calif., Sept. 25, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (NASDAQ:KOD), a precommercial retina-focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced that the company will report topline results from DAYBREAK, a Phase 3 study evaluating both Zenkuda TM (tarcocimab tedromer) and KSI-501 (tabirafusp alfa tedromer) for the treatment of patients with wet age-related macular degeneration, on Monday, September 28, 2026. The webcast can be accessed at the following link DAYBREAK Topline Results Webcast or from the Events and Presen

Addition of leading data and AI services firm deepens CDW’s capabilities, helping organizations build modern data foundations and accelerate AI adoption CDW (NASDAQ:CDW), the strategic end-to-end technology partner that turns customer ambition into outcomes, today announced that it has completed its previously announced acquisition of Lovelytics, a leading data and AI services firm and a member of the Databricks Brickbuilder Partner Network. The acquisition expands CDW's Services & Solutions portfolio and will bring the Lovelytics capabilities to a broader set of customers. Lovelytics helps organizations modernize, govern and use their data to improve performance and deploy AI at scale,

On September 23, 2026, Southland Holdings, Inc. (NYSE:SLND) (the "Company") received notification (the "Notice") from NYSE Regulation of the NYSE American LLC ("NYSE American") that the Company is no longer in compliance with NYSE American’s continued listing standards. Specifically, the Notice states that the Company is not in compliance with the continued listing standards set forth in Sections 1003(a)(i) and 1003(a)(ii) of the NYSE American Company Guide (the "Company Guide"). Section 1003(a)(i) requires a listed company to have stockholders’ equity of $2.0 million or more if the listed company has reported losses from continuing operations and/or net losses in two of its three most rece

User Survey Demonstrates High Satisfaction of the LIBERTY System Expansion of Sales Footprint Expands to Western U.S. as Company Secures First California Customer HINGHAM, Mass., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ:MBOT), announced that it highlighted the continuation of its commercial and growth strategy during an analyst meeting held in New York City on Thursday, September 24, 2026. The Company also highlighted select results from a user survey, available on the Company’s website, conveying high satisfaction with the system. Key Topics Discussed: Expansion of the U.S. footprint is continuing, and the Company is on track to have 12 sales territories by the

Silgan Holdings Inc. (NYSE:SLGN), a leading supplier of sustainable rigid packaging solutions for the world's essential consumer goods products, will release its third quarter 2026 earnings results on Thursday, October 29, 2026, before the U.S. markets open. At 8:00 a.m. eastern time on that day, Silgan will hold a conference call to discuss the Company’s results and performance for this period. Callers in the U.S. and Canada can access the conference call toll free by dialing (800) 330-6710. Callers outside of the U.S. and Canada should dial (312) 471-1353 for the conference call. The confirmation code for the conference call is 6547698. The conference call audio will also be webcast liv

SOUTH SAN FRANCISCO, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, announced today that eight studies leveraging its Decipher Prostate Genomic Classifier test and whole-transcriptome data will be presented at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting. The conference will take place September 26–30 in Boston. The presentations include analyses from Phase II and III clinical trials, Genomic Research for Intelligent Discovery (GRID) research, and national real-world studies. Together, they examine Decipher’s prognostic value in assessing disease risk and predictive value in identifying which patien

 FDA approval supported by data from BRAVE-AA-PEDS, the first and largest Phase 3 study specifically designed to evaluate pediatric patients with severe alopecia areata (AA)Treatment with Olumiant resulted in substantial scalp hair regrowth, as well as improvements in eyebrows and eyelashesSevere AA can result in extensive hair loss during adolescence, a formative stage of lifeINDIANAPOLIS, Sept. 25, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) announced today that the U.S. Food and Drug Administration (FDA) approved Olumiant (baricitinib), a once-daily pill, for the treatment of pediatric patients 12 years of age and older with severe alopecia areata (AA).1 The approval expands Olu

NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Brookfield Real Assets Income Fund Inc. (NYSE:RA) (the "Fund") today announced that its Board of Directors (the "Board") declared the Fund’s monthly distributions for October, November and December 2026. Q4 2026 Distribution Schedule MonthRecord DateEx-Dividend DatePayable DateAmount per ShareOctober 2026October 9, 2026October 9, 2026October 23, 2026$0.1180November 2026November 12, 2026November 12, 2026November 27, 2026$0.1180December 2026December 10, 2026December 10, 2026December 24, 2026$0.1180 Shares purchased on or after the applicable ex-distribution dates will not receive the distributions discussed above. Distributions may include net in

SAN DIEGO, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE:CLDI) ("Calidi" or the "Company"), a biotechnology company pioneering the development of targeted genetic medicines, today announced that on September 21, 2026, the Company received a notice (the "Notice") from the staff of NYSE American LLC (the "NYSE American") that the Company was not in compliance with the NYSE American's continued listing standards in Part 10, Section 1003(a)(ii)of the NYSE American Company Guide (the "Company Guide")requiring a company to have stockholders' equity of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most rec

BOSTON, MA, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (NASDAQ:NCPL) (the "Company") today announced that on September 21, 2026, it received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") stating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 2026, and remains delinquent in filing its Annual Report on Form 10-K for the fiscal year ended April 30, 2026, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1). That rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. As previousl

San Francisco, CA, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Future Money Acquisition Corporation (NASDAQ:FMAC) (the "Company") announced today that on September 22, 2026, the Company received a deficiency letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, because it has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 2026 (the "Form 10-Q"), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission. The Notice states that the Company has 6

LAS VEGAS, Sept. 25, 2026 /PRNewswire/ -- CleanSpark, Inc. (NASDAQ:CLSK) ("CleanSpark" or the "Company"), a market-leading data center developer, today announced that its wholly owned subsidiary, CSDC Finance I, LLC, has closed its previously announced offering of $2.276 billion aggregate principal amount of 7.875% senior secured notes due 2031. The notes have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration. About CleanSparkCleanSpark is a market-leading data center developer with a proven track record of su

Zug, Switzerland, September 25, 2026 – WISeKey International Holding Ltd ("WISeKey" or the "Company") ((SIX: WIHN, NASDAQ:WKEY) today announced that it expects the previously announced redomiciliation of WISeKey from Switzerland to the British Virgin Islands to become effective on October 2, 2026 (the "Redomiciliation"). The Redomiciliation is being implemented through the cross-border merger of WISeKey with and into its wholly owned British Virgin Islands subsidiary, WISeQey Corp. (formerly known as WISeKey International Corp., "WISeQey"), with WISeQey continuing as the surviving company (the "Merger"). The Merger and Redomiciliation are expected to become legally effective on October 2, 20

KANSAS CITY, Mo., Sept. 25, 2026 /PRNewswire/ -- Marking the wind down of baseball season, Sun Life U.S. and the Kansas City Royals Foundation have successfully completed the first "Every Single Smile" campaign, reaching their $50,000 goal to help TeamSmile expand access to dental care for youth in underserved communities across Kansas City. TeamSmile is a leading nonprofit organization providing large-scale dental clinics for local children in cities throughout the country, in partnership with professional sports organizations. Through this season-long initiative, every Royals single generated a donation from Sun Life and the KC Royals Foundation.